Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update. It does not affect the study details, enrollment, results, or other content presented on the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a new deployment/build of the page and does not change the study content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the study record metadata without altering study content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small metadata update to the study record without altering substantive information.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now indicates that recruitment has ended for participants. It adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision noted as v3.6.0.SummaryDifference0.3%

- Check66 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a minor site update. This does not modify the study content or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.